Form 4 for PCVX Vaxcyte, Inc.
Accepted 2024-02-27 00:00:00 ET · period of report 2024-02-23 · accession 0001415889-24-005476 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2024-02-27 | 2024-02-23+ | PCVX | PICKERING GRANT | CEO, Dir | S - Sale+OE | $78.09 | -45.0K | 381.5K | -11% | -$3.51M |
| DM | 2024-02-27 | 2024-02-23+ | PCVX | PICKERING GRANT | CEO, Dir | M - OptEx | $1.79 | +45.0K | 390.8K | +13% | +$80.5K |
| DM | 2024-02-27 | 2024-02-23+ | PCVX | PICKERING GRANT | CEO, Dir | M - OptEx | $0.00 | -45.0K | 60.2K | -43% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-02-23 | S | D | 2,356 | $75.15 | 388,458 | D | — | — | (F2) The price reported is a weighted-average price. The shares were sold at prices ranging from $74.45 to $75.52. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price. |
| 2 | Common | Common Stock | 2024-02-26 | S | D | 30,000 | $79.03 | 375,814 | D | — | — | (F5) The price reported is a weighted-average price. The shares were sold at prices ranging from $79.03 to $79.10. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price. |
| 3 | Common | Common Stock | 2024-02-26 | M | A | 30,000 | $1.79 | 405,814 | D | — | — | |
| 4 | Common | Common Stock | 2024-02-23 | S | D | 119 | $77.56 | 375,814 | D | — | — | |
| 5 | Common | Common Stock | 2024-02-23 | S | D | 5,545 | $76.95 | 375,933 | D | — | — | (F4) The price reported is a weighted-average price. The shares were sold at prices ranging from $76.54 to $77.475. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price. |
| 6 | Common | Common Stock | 2024-02-23 | M | A | 15,000 | $1.79 | 390,814 | D | — | — | |
| 7 | Common | Common Stock | 2024-02-23 | S | D | 6,980 | $75.96 | 381,478 | D | — | — | (F3) The price reported is a weighted-average price. The shares were sold at prices ranging from $75.545 to $76.50. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price. |
| 8 | Derivative | Stock Option (Right to Buy) | 2024-02-26 | M | D | 30,000 | $0.00 | 30,225 | D | $1.79 · — to 2027-05-17 | 30,000 Common Stock | (F8) Stock Option is fully vested and exercisable. |
| 9 | Derivative | Stock Option (Right to Buy) | 2024-02-23 | M | D | 15,000 | $0.00 | 60,225 | D | $1.79 · — to 2027-05-17 | 15,000 Common Stock | (F8) Stock Option is fully vested and exercisable. |